Daniel Passeri

Amministratore Delegato presso CUE BIOPHARMA, INC.

Patrimonio netto: 219 362 $ in data 31/05/2024

63 anni

82 relazioni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Daniel Passeri

Società	Posizione	Inizio	Fine
CUE BIOPHARMA, INC.	Direttore/Membro del Consiglio	01/08/2016	-
	Amministratore Delegato	01/08/2016	-
	Presidente	01/08/2016	07/10/2019

Storia della carriera di Daniel Passeri

Precedenti posizioni note di Daniel Passeri

Società	Posizione	Inizio	Fine
CURIS, INC.	Direttore/Membro del Consiglio	01/09/2011	01/06/2016
	Amministratore Delegato	01/09/2001	02/06/2014
	Corporate Officer/Principal	01/11/2000	01/09/2001
	Presidente	01/09/2001	01/02/2013
Genomic Medicine, Inc. Genomic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Part of GenoMed, Inc., Genomic Medicine, Inc. is a company that researches and studies disease causing genes. The company is based in St. Louis, MO. Genomic Medicine was acquired by GenoMed, Inc. on November 29, 2001 for $1.25 million.	Corporate Officer/Principal	01/12/2014	01/06/2015
Gene Logic, Inc. Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland.	Corporate Officer/Principal	01/03/1997	01/11/2000
Boehringer Mannheim Pharmaceuticals Corp.	Corporate Officer/Principal	01/03/1997	01/03/1997
Xequel Bio, Inc. Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC.	Direttore/Membro del Consiglio	-	-

Formazione di Daniel Passeri

Northeastern University	Undergraduate Degree
Imperial College London	Graduate Degree
George Washington University Law School	Graduate Degree

Statistiche

Distribuzione geografica

Stati Uniti	9
Regno Unito	2

Posizioni

Corporate Officer/Principal	4
Director/Board Member	3
Chief Executive Officer	2

Settori

Health Technology	5
Consumer Services	4
Commercial Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	2
CURIS, INC.	Health Technology
CUE BIOPHARMA, INC.	Health Technology

Aziende private	4
Gene Logic, Inc. Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland.	Health Technology
Boehringer Mannheim Pharmaceuticals Corp.
Xequel Bio, Inc. Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC.	Health Technology
Genomic Medicine, Inc. Genomic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Part of GenoMed, Inc., Genomic Medicine, Inc. is a company that researches and studies disease causing genes. The company is based in St. Louis, MO. Genomic Medicine was acquired by GenoMed, Inc. on November 29, 2001 for $1.25 million.	Commercial Services

Vedi le connessioni aziendali